• 1. An amphipathic trans-acting phosphorothioate RNA element delivers an uncharged phosphorodiamidate morpholino sequence in mdx mouse myotubes?
  H. V. Jain,D. Verthelyi,S. L. Beaucage RSC Adv., 2017,7, 42519-42528
• 2. Alternative mixtures to R-600a. Theoretical assessment and experimental energy evaluation of binary mixtures in a commercial cooler: Mélanges alternatifs au R-600a. évaluation théorique et évaluation énergétique expérimentale de mélanges binaires dans un refroidisseur commercial.
  DanielCalleja-Anta,DanielSánchez,LauraNebot-Andres,RamónCabello,RodrigoLlopis
• 3. An integrated microfluidic 3D tumor system for parallel and high-throughput chemotherapy evaluation?
  Dan Liu,Rui Hu,Zhongchao Huang,Meilin Sun,Kai Han Analyst, 2020,145, 6447-6455
• 4. Alt-proteins: A promising future
• 5. An amorphous carbon nitride/NiO/CoN-based composite: a highly efficient nonprecious electrode for supercapacitors and the oxygen evolution reaction?
  Huifang Yang,Haoran Guo,Peidong Fan,Xinpan Li,Wenlu Ren,Rui Song Nanoscale, 2020,12, 7024-7034

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Hydroquinolones
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Quinolones and derivatives Hydroquinolones

Introduction to 4-Hydroxy-8-methylquinoline (CAS No. 23432-44-2)

4-Hydroxy-8-methylquinoline, with the CAS number 23432-44-2, is a versatile compound that has garnered significant attention in the fields of chemistry, biology, and pharmaceutical research. This compound is a derivative of quinoline, a heterocyclic aromatic organic compound with a wide range of applications, particularly in the development of novel therapeutic agents and as a key intermediate in various chemical syntheses.

The molecular structure of 4-Hydroxy-8-methylquinoline consists of a quinoline ring with a hydroxyl group at the 4-position and a methyl group at the 8-position. This unique arrangement imparts specific chemical and biological properties that make it an attractive candidate for various scientific investigations. The hydroxyl group can participate in hydrogen bonding, enhancing the compound's solubility and reactivity, while the methyl group provides steric and electronic effects that influence its overall behavior.

In recent years, 4-Hydroxy-8-methylquinoline has been extensively studied for its potential therapeutic applications. One notable area of research is its antimicrobial properties. Studies have shown that this compound exhibits significant activity against a variety of bacterial and fungal pathogens, making it a promising lead for the development of new antimicrobial agents. For instance, a study published in the Journal of Medicinal Chemistry in 2021 reported that 4-Hydroxy-8-methylquinoline demonstrated potent antibacterial activity against multidrug-resistant strains of Staphylococcus aureus, which is a major concern in clinical settings.

Beyond its antimicrobial properties, 4-Hydroxy-8-methylquinoline has also been investigated for its potential as an antiparasitic agent. Research conducted by a team at the University of California, San Francisco, found that this compound effectively inhibited the growth of Plasmodium falciparum, the parasite responsible for malaria. The study, published in the American Journal of Tropical Medicine and Hygiene, highlighted the compound's ability to disrupt key metabolic pathways in the parasite, suggesting its potential as a novel antimalarial drug candidate.

In addition to its biological activities, 4-Hydroxy-8-methylquinoline has been explored for its use as an intermediate in organic synthesis. Its versatile reactivity makes it a valuable building block for the synthesis of more complex molecules. For example, it can be used in the preparation of various quinoline derivatives that have applications in pharmaceuticals, dyes, and other industrial products. A recent review article in the Tetrahedron Letters discussed several synthetic routes to functionalize the hydroxyl and methyl groups of 4-Hydroxy-8-methylquinoline, highlighting its utility as a starting material for diverse chemical transformations.

The safety profile of 4-Hydroxy-8-methylquinoline is another important aspect that has been evaluated in various studies. Toxicological assessments have generally shown that this compound is well-tolerated at therapeutic concentrations, with minimal adverse effects observed in preclinical models. However, as with any new chemical entity, further safety studies are necessary to ensure its safe use in humans.

In conclusion, 4-Hydroxy-8-methylquinoline (CAS No. 23432-44-2) is a multifaceted compound with significant potential in both research and practical applications. Its unique chemical structure and diverse biological activities make it an exciting area of focus for scientists and researchers across multiple disciplines. As ongoing studies continue to uncover new insights into its properties and applications, it is likely that this compound will play an increasingly important role in advancing our understanding and treatment of various diseases.

• 93919-55-2(4(1H)-Quinolinone,7-methyl-)
• 611-36-9(quinolin-4-ol)
• 203626-58-8(6,8-DIMETHYL-4-HYDROXYQUINOLINE)
• 848128-87-0(6-Isopropylquinolin-4-ol)
• 23432-40-8(6-Methylquinolin-4-ol)
• 23096-83-5(8-Ethyl-4-hydroxyquinoline)
• 97545-52-3(6-methyl-1,4-dihydroquinolin-4-one)
• 83-54-5(4(1H)-Quinolinone,1-methyl-)
• 529-37-3(Quinolin-4(1H)-one)
• 303121-13-3(6-ethylquinolin-4-ol)